Ashish Nanda - 23 Jul 2024 Form 4 Insider Report for Orgenesis Inc. (ORGS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Jul 2024, 11:25:45 UTC
Prior SEC filing
21 Dec 2023
Next SEC filing
16 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ashish Nanda

Key filing fact

Ashish Nanda filed Form 4 for Orgenesis Inc. (ORGS) on 25 Jul 2024.

Key facts

  • This page summarizes Ashish Nanda's Form 4 filing for Orgenesis Inc. (ORGS).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 25 Jul 2024, 11:25.

Change

  • Previous filing in this sequence was filed on 21 Dec 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORGS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+189,320
Change %
Price
$0.000000
Shares after
189,320
Date
23 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
189,320
Exercise price
$0.6400
ORGS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+189,320
Change %
Price
$0.000000
Shares after
189,320
Date
23 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
189,320
Exercise price
$1.03
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .